18 May 2013
Keywords: janssen, contests, lilly, risperdal/zyprexa, study, janssen-cilag, told
Article | 03 July 1997
Janssen-Cilag told the Marketletter at the 6th World Congress ofBiological Psychiatry in Nice, France, that it is strongly contesting Eli ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.